UNSPSC 51334309: Chlorprothixene hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C18H18ClNS.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 268KCR965N, chemically known as 1-propanamine, 3-(2-chloro-9h-thioxanthen-9-ylidene)-n,n-dimethyl-, (z)- but more generally known as chlorprothixene hydrochloride, which bears US NIH Compound Identifier 667466. European Medicines Agency schedules Chlorprothixene hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01257MIG.

Most nations, for tariff and trade purposes, schedule chlorprothixene hydrochloride under HS 29349910 and SITC 51579. As of Q4 2014, CHLORPROTHIXENE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)CC/C=C\1/C2CCCCC2SC3C1CC(CC3)CL.CL.

UNSPSC 51334309 Chlorprothixene hydrochloride is a Commodity code that designates a specific antipsychotic pharmaceutical, yet the recent state and local solicitation activity under this code does not align with the nominal scope. The single recent opportunity—Seminole County, Florida's IFB for Naloxone and Drug Deactivation Systems—names products (naloxone, a fast-acting opioid antagonist, and drug deactivation systems) that fall outside chlorprothixene's therapeutic class and mechanism. This mismatch signals a tagging error in the underlying opportunity record rather than substantive procurement activity for chlorprothixene itself under this code.

The Seminole County IFB (solicitation number IFB60459723LAS, posted June 30, 2026, with response deadline July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year term with one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building. The procurement required electronic bid submission through the county's e-Procurement Portal, unit pricing for each line item, E-Verify compliance, and standard insurance coverage (workers' compensation, commercial general liability, professional liability). The contract noted potential FEMA funding and associated federal compliance requirements. No explicit set-asides for disadvantaged enterprises were specified. This single opportunity provides insufficient evidence of sustained or material state and local demand for chlorprothixene hydrochloride as a stand-alone procurement line; firms should verify the code's actual mapping in their target jurisdictions' taxonomies before pursuing activity under it.